BOLD Innovators podcast

Acting without fear: Patricia Cornet, executive director, Patient Advocacy, hematology and oncology

Episode Summary

In this month's episode, we are delighted to feature Patricia Cornet, executive director of Patient Advocacy in hematology and oncology. Hosting the episode is Bryant Powell, associate director of social media in Omni-Channel Capabilities and the host of the BOLD Innovators podcast series. Pat leads the Patient Advocacy oncology, hematology and CAR-T team. Her primary focus is to amplify the patient voice and promote health equity perspectives within our company and the industry. She and her team develop strategies for key accounts while fostering a collaborative environment to strengthen internal and external partnerships. Their goal is to advance research, improve access and enhance patient education initiatives in cancer care. She is a founding member of Women of Color in Pharma (WOCIP), a non-profit organization that seeks to empower women of color in pharma to excel in their personal and professional development and to transform their pathway within the pharmaceutical industry. During the interview, Pat shares an eye-opening moment from her career after returning to the U.S. from an assignment with BMS in China. She reflects on the importance of actively participating and having a seat at the table. In the past, she often found herself sitting at the back of the room and not fully leveraging her voice. She now realizes the significance of exerting oneself and actively engaging in discussions. On urgency at work, Pat emphasizes the importance of self-awareness and self-knowledge. She suggests utilizing self-assessment tools to gain a deeper understanding of oneself. By knowing our strengths and weaknesses, especially in situations where urgency is not a natural trait, we can better navigate our professional journeys.

Episode Notes

Please visit our website to listen to more BOLD Innovators podcast episodes or to learn more about Bristol Myers Squibb, a global leading biopharmaceutical organization.